… in randomized controlled trials (RCTs) would … real-world treatment patterns (ie, treatment switching and … Pharmaceuticals, Inc. was given the opportunity to review the manuscript for medical … randomized pragmatic trial, AIR-WISE, comparing tiotropium/ …

… region. The introduction of FDA-approved treatments like Ohtuvayre by Verona … traditional devices. Lupin Pharmaceuticals introduced generic Tiotropium Bromide Inhalation Powder in … Inc. BMC Medical Co., Ltd. Medtronic Trudell Medical International Novartis AG …

… Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, for the treatment … landscape, pipeline drug profiles, including … MediciNova, Edesa Biotech, Light Chain Biosciences, Boehringer Ingelheim, Genentech, Windtree Therapeutics, Biomarck Pharmaceuticals …

… corticosteroid indicated for the treatment of postoperative inflammation … from the Food and Drug Administration for loteprednol … Lupin, Sino Universal Pharmaceuticals ink deal for tiotropium DPI in China … [Read more: Lupin receives FDA OK for generic Banzel] …

… of American Medical Association identified … drug';s respiratory benefits. This study examined whether initiating tiotropium … treatment between 2004 and 2012. All participants were newly prescribed either tiotropium … target trial emulation framework, …

… [Read more: Lupin receives FDA OK for generic Banzel] … solutions.” [Read more: FDA gives Lupin tentative nod for … Lupin, a global pharmaceutical leader, on Tiotropium DPI,” said Wang … breakthroughs in respiratory disease treatment in China, allowing more …

… with Lupin, a global pharmaceutical leader, on Tiotropium DPI,” said Wang Li … deep commitment to respiratory disease treatment and its innovation-driven approach … significant breakthroughs in respiratory disease treatment in China, allowing more patients …

… whether the initiation of tiotropium monotherapy affects the risk … with COPD should avoid tiotropium due to concerns about … measures, and other anticholinergic drugs. The assumption that the … The data for midlife medication dispensing and dementia biomarkers …

… trials have demonstrated its benefits, establishing these combinations as a key treatment … of individual medications, pharmaceutical manufacturers, dosages, or various drug combinations. However … -daily indacaterol versus tiotropium for patients with severe …

… with Lupin, a global pharmaceutical leader, on Tiotropium DPI," said Wang … deep commitment to respiratory disease treatment and its innovation-driven approach … significant breakthroughs in respiratory disease treatment in China, allowing more patients …